Driehaus Capital Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.2M | Sell |
|
|||||
|
2025
Q1 | $43.8M | Sell |
|
|||||
|
2024
Q4 | $65.3M | Buy |
|
|||||
|
2024
Q3 | $20.2M | Hold |
|
|||||
|
2024
Q2 | $16.2M | Hold |
|
|||||
|
2024
Q1 | $26.1M | Sell |
|
|||||
|
2023
Q4 | $16.6M | Sell |
|
|||||
|
2023
Q3 | $9.81M | Buy |
|
|||||
|
2023
Q2 | $2.09M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.39M | Sell |
|
|||||
|
2020
Q4 | $3.28M | Sell |
|
|||||
|
2020
Q3 | $2.99M | Sell |
|
|||||
|
2020
Q2 | $3.98M | Buy |
|